Subject Code List for Classification of Articles Submitted
Describe the manuscript you are submitting by selecting the most appropriate descriptor number:
ASTHMA
1.1 Airway Receptors: Nerves and Smooth Muscle
1.2 Airway Receptors: Cytokines, Chemokines
1.3 Airway Remodeling: Asthma Mediators
1.4 Airway Remodeling: Smooth Muscle, Fibroblasts, Extracellular Matrix
1.5 Airway Remodeling: Functional Consequences
1.6 Airway Remodeling: Asthma Genes and Gene Products
1.7 Airway Responsiveness: Immunologic Mechanisms
1.8 Airway Responsiveness: Physiology
1.9 Allergic Mechanisms
1.10 Asthma Mediators
1.11 Clinical Asthma
1.12 Clinical Asthma Management Programs
1.13 Education/Self-Management/Asthma Guidelines
1.14 Epidemiology: Adult Asthma: Outcomes
1.15 Epidemiology: Adult Asthma: Risk Factors (Etiology)
1.16 Epidemiology (Pediatric): Outcomes & Management
1.17 Epidemiology (Pediatric): Risk Factors
1.18 Genetics
1.19 Immunology/Inflammation: Animal Models
1.20 Immunology/Inflammation: Human Studies
1.21 Infectious Mechanisms
1.22 Non-Invasive Assessment of the Airways: Functional
1.23 Non-Invasive Assessment of the Airways: Immunological
1.24 Methods on Non-Invasive Assessment of the Airways: Exhaled Breath and Condensates
1.25 Occupational and Environmental Airways Disease
1.26 Rhinitis & Sinusitis
1.27 Therapy
BEHAVIORAL SCIENCE
2.1 Adherence/Compliance/Self-Regulation
2.2 Assessing and Improving Clinician Behavior
2.3 Health Education/Disease Prevention/Patient Education
2.4 Health Outcomes Assessment/Cost Effectiveness
2.5 Health Policy, Financing, and Organization
2.6 Information Technology/Informatics/Telemedicine
2.7 Professional Education/Training/Certification
2.8 Psychosocial and Behavioral Factors in Lung Disease
2.9 Racial, Ethnic, or Social Disparities in Lung Disease and Treatment
2.10 Research Design/Program Evaluation/Statistical Models
2.11 Social Determinants of Lung Health and Disease
2.12 End of Life: Critical Care
2.13 End of Life/Palliative Care
CELL AND MOLECULAR BIOLOGY
3.1 Animal Models of Pulmonary Fibrosis
3.2 Bioinformatics/Biological Computing
3.3 Developmental Lung Biology
3.4 Endothelium
3.5 Epigenetics
3.6 Functional Genomics/Proteomics
3.7 Gene Regulation: Developmental Control/Mouse Models
3.8 Gene Regulation: General and Tissue Specific
3.9 Growth Factors and Receptors
3.10 Ion Transport and Membrane Channels
3.11 Pulmonary Fibrosis/Fibroblast Biology
3.12 Signal Transduction: Intracellular Pathways
3.13 Signal Transduction: Membrane Receptors
3.14 Smooth Muscle: Airway
3.15 Smooth Muscle: Vascular
3.16 Transcription Factors
3.17 Cell Fate, Inflammatory Cells: Apoptosis
3.18 Cell Fate, Inflammatory Cells: Clearance of Apoptotic Cells
3.19 Cell Fate, Inflammatory Cells: Survival
3.20 Cell Fate, Inflammatory Cells: Proliferation
3.21 Cell Fate, Non-Inflammatory Cell Types: Cell Plasticity
3.22 Cell Fate, Non-Inflammatory Cell Types: Injury/Repair
3.23 Cell Fate, Non-Inflammatory Cell Types: Senescence
3.24 Cell Fate, Non-Inflammatory Cell Types: Stem Cells/Tissue Regeneration
3.25 Cell Fate, Non-Inflammatory Cell Types: Survival/Apoptosis/Cell Cycle
3.26 Cell Fate, Vascular Cell: Apoptosis
3.27 Cell Fate, Vascular Cell: Survival
3.28 Cell Fate, Vascular Cell: Proliferation
3.29 Cell-Cell Interactions
3.30 Cell-Matrix Interactions
3.31 Airway General
3.32 Airway Gene Expression
3.33 Airway Inflammation
3.34 Airway Mucins
3.35 Alveolar General
3.36 Alveolar Gene Expression
3.37 Surfactant Gene Expression
3.38 Surfactant Function
CRITICAL CARE
4.1 ALI/ARDS: Biological Mechanisms
4.2 ALI/ARDS: Diagnosis & Clinical Issues
4.3 Cardiopulmonary Interactions/CV Performance
4.4 Clinical Trials in Critical Care Medicine
4.5 Diagnostic Techniques & Monitoring
2.12 End of Life: Critical Care
4.6 ICU Management/Outcome
4.7 Mechanical Ventilation: Applications
4.8 Mechanical Ventilation: Physiology & Pathophysiology
4.9 Molecular Biology of Critical Care
4.10 Non-Pulmonary Critical Care
4.11 Pediatric Critical Care
4.12 Sepsis/Multiple Organ Failure
4.13 Ventilation: Non-Invasive/Long-Term/Weaning
CHEMOKINES AND MEDIATORS
5.1 Chemokines: Immune Effects
5.2 Eicosanoids, Immune Effects
5.3 Immune Effects
ENVIRONMENTAL AND OCCUPATIONAL HEALTH
6.1 Air Pollution: Epidemiology
6.2 Air Pollution: Mechanisms
9.6 COPD: Epidemiology
6.3 Diet, Obesity and Lung Disease
6.4 Epidemiology
1.14 Epidemiology: Adult Asthma: Outcomes
1.15 Epidemiology: Adult Asthma: Risk Factors (Etiology)
1.17 Epidemiology (Pediatric): Risk Factors
6.5 Functional Genomics and Proteomics of Environmental and Occupational Lung Disease
6.6 Gene-Environment Interaction
6.7 Genetic Epidemiology of Environmental and Occupational Lung Disease
6.8 Global Burden of Occupational and Environmental Lung Diseases
6.9 Health Effects of Nanomaterials
6.10 Hypersensitivity Pneumonitis
6.11 Inhalational Disasters Science and Health
6.12 Lung Cancer Epidemiology: Occupational and Environmental Factors
6.13 Lung Health and the Working Life
6.14 Medical Monitoring and Screening for Occupational and Environmental Respiratory Diseases
1.25 Occupational and Environmental Airways Disease
6.15 Occupational and Environmental Pleural and Lung Disease
6.16 Pulmonary Toxicology
6.17 Smoking Health Effects
6.18 Smoking: Prevention/Education/Cessation
6.19 Upper Airway: Occupational and Environmental Factors
6.20 Indoor Air
IMMUNOLOGY AND INFLAMMATION
7.1 Aerosols: Physiology and Biology
7.2 Aerosols: Therapy
7.3 Animal Models of Airway Fibrosis
7.4 Complement, Defensins, and Other Humoral Mediators of Innate Immunity
7.5 Dendritic Cells
7.6 Eosinophils
7.7 Immunology: General
7.8 Inflammation: Cell-Cell Interactions
7.9 Inflammation: General
7.10 Inflammation/Lung Injury
7.11 Inflammation: Resolution and Repair
7.12 Inflammatory Cell Activation, Co-Stimulation and Proliferation
7.13 Inflammatory Cell Recruitment
7.14 Innate Immune Responses: Molecular Aspects
7.15 Lymphocytes
7.16 Macrophages
7.17 Mast Cells
7.18 Mucosal Immunity of the Respiratory Tract
7.19 Neutrophils
1.26 Rhinitis & Sinusitis
INTEGRATIVE PHYSIOLOGY AND PATHOLOGY
7.1 Aerosols: Physiology and Biology
8.1 Airway Neural Control
8.2 Airway Pathology & Structure
1.8 Airway Responsiveness: Physiology
8.3 Altitude and Hypoxia
8.4 Alveolar Pathology and Structure
8.5 Animal Models of Bronchial Circulation
8.6 Application of Nanotechnology
8.7 Bronchial Circulation
8.8 Control of Ventilation: Cellular Mechanisms
8.9 Control of Ventilation: Physiology
8.10 Cough: Fundamental Mechanisms
8.11 Dyspnea: Functional Mechanisms
8.12 Dyspnea: Neural Mechanisms
8.13 Exercise in Health & Disease
8.14 Gas Exchange
8.15 Imaging: Animal Models
8.16 Imaging: Emerging Technologies
8.17 Imaging: Physiologic Correlates
8.18 Intermittent Hypoxia
8.19 LAM: Fundamental Mechanisms
8.20 Mechanics of Breathing
8.21 Modeling: Structure Function Relationships
8.22 Peripheral Muscle Function In Lung Disease
8.23 Pulmonary Acoustics
8.24 Pulmonary Laboratory Science: Methodology
8.25 Respiratory Muscles: Cell Biology
8.26 Respiratory Muscles: Disease/Rehabilitation
8.27 Respiratory Muscles: Function/Fatigue
8.28 Upper Airway: Sleep
LUNG DISEASES
2.1 Adherence/Compliance/Self-Regulation
9.1 Adult Cystic Fibrosis
3.1 Animal Models of Pulmonary Fibrosis
9.2 Animal Models of Pulmonary Hypertension
9.3 COPD: Clinical Phenotypes
9.4 COPD: Comorbidities
9.5 COPD: Diagnosis & Evaluation
9.6 COPD: Epidemiology
9.7 COPD: Exacerbations
9.8 COPD: Functional Assessment (Exercise)
9.9 COPD: General
9.10 COPD: Multidisciplinary Programs
9.11 COPD: Non-Pharmacological Treatment
9.12 COPD: Outcomes
9.13 COPD: Pathogenesis
9.14 COPD: Pharmacological Treatment
9.15 Cough: Clinical
9.16 Cystic Fibrosis: Basic Studies
9.17 Cystic Fibrosis: Translational & Clinical Studies
9.18 Dyspnea: Clinical
8.11 Dyspnea: Functional Mechanisms
8.12 Dyspnea: Neural Mechanisms
9.19 Emphysema: Animal Models
9.20 Gender Issues
9.21 Gene Therapy: Cellular and Molecular Aspects
9.22 Gene Therapy: Clinical Applications
6.10 Hypersensitivity Pneumonitis
9.23 Interstitial Lung Disease
9.24 Interventional Pulmonology/Bronchoscopy
9.25 LAM: Clinical
9.26 Lung Cancer: Cellular and Molecular Aspects
9.27 Lung Cancer: Clinical Aspects
9.28 Lung Cancer: Epidemiology
9.29 Lung Reduction
9.30 Other Diffuse Lung Diseases/Drug Related Lung Diseases
9.31 Pleural Diseases/Mesothelioma
9.32 Pulmonary Edema
9.33 Pulmonary Embolism
9.34 Pulmonary Hypertension: Clinical-Treatment
9.35 Pulmonary Hypertension: Clinical-Diagnosis/Pathogenesis/Outcome
9.36 Pulmonary Laboratory Science: Clinical Application
9.37 Pulmonary Rehabilitation
9.38 Sarcoidosis: Clinical Evaluation and Treatment
9.39 Sarcoidosis: Mechanisms
9.40 Symptom Assessment & Management
MICROBIOLOGY AND PULMONARY INFECTIONS
10.1 Agents of Biological Warfare
10.2 AIDS-Related Lung Disease
10.3 Chronic Bronchial Suppurative Diseases
10.4 Diagnosis of Infections
10.5 Epidemiology
10.6 Host Defenses to Microbial Pathogens
10.7 Nosocomial Infections
10.8 Opportunistic Infections
10.9 Pathogen/Host Cell Interactions
10.10 Pathogenic Mechanisms of Infections
10.11 Pediatrics: Respiratory Infections
10.12 Pneumonia: Bacterial Infections
10.13 Pneumonia: Fungal Infections
10.14 Pneumonia: Viral Infections
10.15 Treatment
MYCOBACTERIAL DISEASES
11.1 Diagnosis of Tuberculosis or Latent Infection
11.2 Epidemiology of Tuberculosis
11.3 Mycobacterial Disease & HIV Infection
11.4 Mycobacterial Disease: Host Defenses
11.5 Non-Tuberculous Mycobacterial Disease
11.6 Treatment of Tuberculosis or Latent Infection
NURSING
12.1 Complimentary and Alternative Therapy
9.15 Cough: Clinical
12.2 Critical Care: Nursing and Implementation Consideration
9.18 Dyspnea: Clinical
2.13 Ethics: End of Life/Palliative Care
12.3 Functional Ability/Impairment/Quality of Life/Physical Activity
12.4 Pediatrics: Nursing and Implementation Consideration
9.37 Pulmonary Rehabilitation
12.5 Sleep: Nursing and Implementation Consideration
6.18 Smoking: Prevention/Education/Cessation
9.40 Symptom Assessment & Management
PATHOPHYSIOLOGY
4.1 ALI/ARDS: Biological Mechanisms
4.2 ALI/ARDS: Diagnosis & Clinical Issues
13.1 Alpha 1 Antitrypsin: Cellular and Molecular Aspects
8.15 Imaging: Animal Models
8.16 Imaging: Emerging Technologies
8.17 Imaging: Physiologic Correlates
13.2 Matrix Metalloproteinases: Cellular and Molecular Aspects
13.3 Nitric Oxide, Carbon Monoxide
13.4 Oxidants/Antioxidants
PEDIATRICS
14.1 Clinical Studies: Asthma
14.2 Clinical Studies: General
9.16 Cystic Fibrosis: Basic Studies
9.17 Cystic Fibrosis: Translational & Clinical Studies
3.3 Developmental Lung Biology
1.16 Epidemiology (Pediatric): Outcomes & Management
1.17 Epidemiology (Pediatric): Risk Factors
14.3 Neonatal Lung Disease & BPD
4.11 Pediatric Critical Care
14.4 Pediatric Pulmonary Measurement Techniques & Basic Studies
14.5 Pediatric Sleep and Control of Breathing
10.11 Pediatrics: Respiratory Infections
14.6 Rare Pediatric Lung Disease
14.7 Bronchopulmonary Dysplasia
SLEEP
15.1 Animal Models of Sleep Apnea
8.8 Control of Ventilation: Cellular Mechanisms
15.2 Control of Ventilation During Sleep
8.9 Control of Ventilation: Physiology
8.12 Dyspnea: Neural Mechanisms
15.3 Genetics of Sleep Disorders
8.18 Intermittent Hypoxia
15.4 Neuroendocrine Aspects of Sleep-Disordered Breathing
14.5 Pediatric Sleep and Control of Breathing
15.5 Sleep Disordered Breathing: Cardiovascular Interactions
15.6 Sleep Disordered Breathing: Diagnosis
15.7 Sleep Disordered Breathing: Epidemiology
15.8 Sleep Disordered Breathing: Management
15.9 Sleep Disordered Breathing: Outcomes
15.10 Sleep: Other
8.28 Upper Airway: Sleep
SMOKING/TOBACCO
6.18 Smoking: Prevention/Education/Cessation
THORACIC SURGERY/TRANSPLANTATION
9.24 Interventional Pulmonology/Bronchoscopy
16.1 Thoracic Surgery: General
16.2 Transplantation
16.3 Transplantation: Animal Models/Xenographing
16.4 Transplantation: Experimental
VASCULAR BIOLOGY/PULMONARY CIRCULATION
17.1 Developmental Aspects of the Pulmonary Circulation
3.4 Endothelium
17.2 Pulmonary Circulation: Cell-Matrix Interactions
17.3 Pulmonary Circulation: General
17.4 Pulmonary Circulation: Hemodynamics
17.5 Pulmonary Circulation: Sepsis
9.32 Pulmonary Edema
9.33 Pulmonary Embolism
9.34 Pulmonary Hypertension: Clinical-Treatment
9.35 Pulmonary Hypertension: Clinical-Diagnosis/Pathogenesis/Outcome
17.6 Pulmonary Hypertension: Experimental
17.7 Right Ventricle: Function and Dysfunction
3.15 Smooth Muscle: Vascular
17.8 Vascular Genetics, Cell & Molecular Biology
17.9 Vascular Inflammation/Leak
17.10 Vascular Remodelling
17.11 Vasoreactivity
MISCELLANEOUS
18.1 Neuromuscular Disease (Adults)
